BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 233 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $251 | +0.4% | 35,500 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $250 | -15.5% | 35,500 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $296 | -27.5% | 35,500 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $408 | -99.9% | 35,500 | +31.0% | 0.00% | +50.0% |
| Q3 2022 | $341,000 | -9.8% | 27,100 | -24.1% | 0.00% | 0.0% |
| Q2 2022 | $378,000 | -34.8% | 35,700 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $580,000 | -11.0% | 35,700 | -24.2% | 0.00% | 0.0% |
| Q4 2021 | $652,000 | -30.9% | 47,100 | -28.3% | 0.00% | -40.0% |
| Q3 2021 | $944,000 | +0.3% | 65,700 | +10.4% | 0.01% | 0.0% |
| Q2 2021 | $941,000 | – | 59,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |